Neonatal Hypoglycaemia Threshold Interpreter

Newborn blood glucose read against the BAPM operational thresholds, which are lower than adult thresholds and depend on whether the baby has abnormal clinical signs — and on whether the number came from a laboratory or from a cot-side glucometer.

Last updated 12 Sep 2026

Neonatal blood glucose

Glucose + signs + method → interpretation

Blood glucose (mmol/L)Divide mg/dL by 18 to get mmol/L, so 2.0 mmol/L is 36 mg/dL and 2.6 mmol/L is 47 mg/dL. Enter the value exactly as measured, whichever method produced it — the method is asked for separately below.

How was it measured?This is not a formality. Handheld glucometers are least accurate precisely where the decision is being made, at low concentrations, and a glucometer reading near a threshold needs confirming by a method that can be trusted there.

Clinical signsAbnormal clinical signs change the threshold. A baby who is symptomatic is treated at a higher glucose than a baby who is merely at risk, because the signs are evidence that this particular baby is not tolerating this particular level.

Is this a first or a repeat measurement?BAPM's operational threshold for an at-risk but asymptomatic baby is a value below 2.0 mmol/L that stays low on a subsequent measurement after feeding — a single low value prompts a feed and a recheck rather than immediate escalation.

Below the 2.0 mmol/L operational thresholdExample

Blood glucose 1.6 mmol/L on a cot-side glucometer, no abnormal clinical signs, first measurement below the threshold

BAPM operational thresholds in the full-term infant

BAPM's 2017 framework was written for the full-term infant, and the 2.6 mmol/L figure widely used for preterm babies and for babies on treatment comes from unit guidelines rather than from that framework. This site does not put a single number on the hyperinsulinism target because the published sources do not agree on one.
Situation	Threshold	In mg/dL
Any baby, at any time	Below 1.0 mmol/L — severe hypoglycaemia, admit for intravenous glucose	18
Abnormal clinical signs	A single value below 2.5 mmol/L — treat as an emergency	45
At risk, asymptomatic	Below 2.0 mmol/L on a measurement and still below on a subsequent one after a feed	36
Preterm, or on treatment (local practice)	2.6 mmol/L is the figure many UK units apply	47
Suspected congenital hypoglycaemia disorder	A higher target set by the specialist team; published figures differ between sources	—

Why the number itself may be wrong

Every one of these biases the result low except the last, which biases it high. A neonatal glucose that does not fit the clinical picture is worth repeating properly before it is acted on — provided that repeating it does not delay treating a baby who looks unwell.
Problem	Effect on the result	What to do
Handheld glucometer at low concentrations	Least accurate exactly where the decision is made; can err in either direction	Confirm on a laboratory or blood gas sample — and treat while waiting, do not wait to treat
Delay before the sample is processed	Glycolysis in the tube consumes glucose, roughly 0.5 mmol/L per hour at room temperature	Process promptly, or collect into fluoride oxalate
High haematocrit, common in newborns	More cells means more glycolysis, and affects some glucometer chemistries directly	Prefer a blood gas analyser or laboratory method
Squeezed heel, poor flow	Tissue fluid dilutes the sample	Warm the heel and take a free-flowing sample
Sample taken after a feed rather than before	Overstates the trough the baby actually reaches	Time measurements before feeds, as the screening schedule specifies

A different threshold, a different sample, a different urgency

Adult thresholds for hypoglycaemia do not apply to newborns. A healthy term baby's glucose falls in the first hours after birth as the placental supply is cut off, reaching a nadir at around one to two hours of age before recovering as counter-regulatory hormones, glycogenolysis, gluconeogenesis and ketogenesis take over. Ketone bodies are an alternative cerebral fuel, and a well term baby who is feeding tolerates a glucose that would be treated urgently in an adult. This is why the numbers on this page are lower than the ones in a general chemistry reference range, and why applying an adult threshold to a newborn produces unnecessary admissions and separations from the mother.

It is equally why the thresholds are described as operational rather than diagnostic. There is no glucose concentration at which neurological injury reliably begins, and BAPM's framework is explicit that its figures are levels at which action should be taken in defined circumstances, not a definition of disease. That is also why the threshold moves with the clinical situation: below 1.0 mmol/L at any time in any baby, below 2.5 mmol/L in a baby with abnormal clinical signs, and below 2.0 mmol/L persisting after a feed in a baby who is merely at risk. The same number means different things depending on what the baby is doing.

The measurement itself is the second problem, and in practice the larger one. Handheld glucometers are designed and validated for adults with diabetes in the range around and above normal, and their performance falls away at exactly the low concentrations where a neonatal decision is being made. A high haematocrit, which is normal in a newborn, affects several glucometer chemistries directly. The consequence is a rule that has to be stated in both halves: a low cot-side reading needs laboratory or blood gas confirmation, and treatment is not delayed while that confirmation is obtained. A baby who looks unwell or whose reading is very low is fed or given glucose now, with the confirmatory sample taken at the same time.

Pre-analytical handling matters as much as the analyser. Red and white cells in a collected sample continue to consume glucose, and in an uninhibited tube the measured concentration falls by roughly half a millimole per litre per hour at room temperature — more with a high haematocrit or a high white cell count, and a newborn commonly has both. A sample that sits on a bench before it is centrifuged can therefore manufacture a hypoglycaemia that never existed, or deepen a real one. Either the sample is processed promptly or it goes into a fluoride oxalate tube, and even fluoride takes time to inhibit glycolysis fully. When the glucose is low and a hypoglycaemia screen is being sent, the whole set — insulin, C-peptide, cortisol, growth hormone, free fatty acids, beta-hydroxybutyrate, lactate and ammonia — must be drawn while the glucose is still low, because a screen taken after the glucose has been corrected answers no question at all.

Frequently asked questions

What blood glucose is too low in a newborn?

BAPM's operational thresholds are: below 1.0 mmol/L at any time in any baby, below 2.5 mmol/L in a baby with abnormal clinical signs, and below 2.0 mmol/L persisting on a repeat measurement after a feed in an at-risk but asymptomatic baby. Many UK units apply 2.6 mmol/L to preterm babies and to babies on treatment.

Can a cot-side glucometer be used to diagnose neonatal hypoglycaemia?

Not on its own. Handheld glucometers are least accurate at low concentrations, which is exactly where the neonatal decision is made, and a high neonatal haematocrit affects several of them directly. A low reading needs laboratory or blood gas confirmation — but treatment is started while that confirmation is awaited, not after it.

Why does a glucose sample need a fluoride tube?

Because red and white cells keep consuming glucose after the sample is collected. In an uninhibited tube the measured concentration falls by roughly 0.5 mmol/L per hour at room temperature, more with a high haematocrit. Fluoride oxalate inhibits glycolysis, and prompt processing does the same job.

Why are newborn thresholds lower than adult ones?

Because a healthy newborn's glucose falls physiologically after birth and the brain uses ketone bodies as an alternative fuel while counter-regulatory metabolism establishes itself. Applying an adult threshold to a term baby who is feeding well produces needless admissions without benefit.

When should a hypoglycaemia screen be taken?

While the glucose is still low, before it is corrected. Insulin, C-peptide, cortisol, growth hormone, free fatty acids, beta-hydroxybutyrate, lactate, ammonia and a urine sample are only interpretable against a simultaneous low glucose; the same set taken after treatment answers nothing.

Related calculators

References

British Association of Perinatal Medicine. Identification and Management of Neonatal Hypoglycaemia in the Full Term Infant: A Framework for Practice. London: BAPM; 2017.
Hay WW Jr, Raju TNK, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia. J Pediatr. 2009;155(5):612–617.
Beardsall K. Measurement of glucose levels in the newborn. Early Hum Dev. 2010;86(5):263–267.
Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238–245.

Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.